Literature DB >> 33758714

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine.

Sadia Waheed1, Angel Bayas1, Fawzi Hindi1, Zufe Rizvi1, Patricio S Espinosa1.   

Abstract

Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine.
Copyright © 2021, Waheed et al.

Entities:  

Keywords:  covid-19 vaccine; guillain-barre syndrome (gbs); neurologic complications

Year:  2021        PMID： 33758714      PMCID： PMC7978140          DOI： 10.7759/cureus.13426

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  72 in total

Review 1.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 2.  A review of adverse effects of COVID-19 vaccines.

Authors:  Hisham Ahmed Mushtaq; Anwar Khedr; Thoyaja Koritala; Brian N Bartlett; Nitesh K Jain; Syed Anjum Khan
Journal:  Infez Med       Date:  2022-03-01

3.  A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination.

Authors:  Yash Kripalani; Vidyadhara Lakkappan; Lipeeka Parulekar; Anjum Shaikh; Rakesh Singh; Pradeep Vyas
Journal:  Eur J Case Rep Intern Med       Date:  2021-09-14

Review 4.  Case Series of Guillain-Barré Syndrome After the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine.

Authors:  Miranda Mengyuan Wan; Angela Lee; Ronak Kapadia; Christopher Hahn
Journal:  Neurol Clin Pract       Date:  2022-04

5.  [Covid-19, Guillain-Barré Syndrome, And The Vaccine: A Dangerous Combination].

Authors:  Ismael Francisco Aomar-Millán; Javier Martínez de Victoria-Carazo; José Antonio Peregrina-Rivas; Inmaculada Villegas-Rodríguez
Journal:  Rev Clin Esp       Date:  2021-06-05       Impact factor: 1.556

Review 6.  Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review.

Authors:  Haruki Koike; Atsuro Chiba; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2021-06-12

7.  New-Onset Neurologic Symptoms and Related Neuro-Oncologic Lesions Discovered After COVID-19 Vaccination: Two Neurosurgical Cases and Review of Post-Vaccine Inflammatory Responses.

Authors:  Evan H Einstein; Andia Shahzadi; Likowsky Desir; Joshua Katz; John Boockvar; Randy D'Amico
Journal:  Cureus       Date:  2021-06-15

8.  Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination.

Authors:  Josef Finsterer
Journal:  IDCases       Date:  2021-07-12

9.  Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.

Authors:  Almurtada Razok; Abdullah Shams; Ahmed Almeer; Muhammad Zahid
Journal:  Ann Med Surg (Lond)       Date:  2021-07-03

10.  Case of Guillain-Barré syndrome following COVID-19 vaccine.

Authors:  Tanveer Hasan; Mustafizur Khan; Farhin Khan; Ghanim Hamza
Journal:  BMJ Case Rep       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.